Acrivon Therapeutics
ACRV
#10118
Rank
A$97.92 M
Marketcap
A$2.29
Share price
-1.86%
Change (1 day)
-26.80%
Change (1 year)

Acrivon Therapeutics (ACRV) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$17.97 Million

According to Acrivon Therapeutics's latest financial reports the company's total liabilities are A$17.97 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Acrivon Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$15.79 M-91.22%
2021-12-31A$0.17 B1204.97%
2020-12-31A$13.78 M